Anthony DiMeo | executive |
Chirag Patel | executive |
Chintu Patel | executive |
Anastasios Konidaris | executive |
Nathan Rich | analyst |
David Amsellem | analyst |
Harsher Singh | executive |
Balaji Prasad | analyst |
Christopher Schott | analyst |
Leszek Sulewski | analyst |
Good morning, and welcome to Amneal Pharmaceuticals Fourth Quarter and Full Year 2023 Earnings Call. I'll now turn the call over to Amneal's Head of Investor Relations, Anthony DiMeo.
Good morning, and thank you for joining Amneal Pharmaceuticals Fourth Quarter 2023 Earnings Call. Today, we issued a press release reporting Q4 and full year 2023 results. The earnings press release and presentation are available at amneal.com.